285.83 -1.97 (-0.69%)
After hours: 5:05PM EDT
|Bid||0.00 x 1000|
|Ask||0.00 x 1000|
|Day's Range||282.00 - 289.95|
|52 Week Range||128.70 - 292.70|
|PE Ratio (TTM)||35.58|
|Earnings Date||Jul 25, 2018 - Jul 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||215.55|
The Zacks Analyst Blog Highlights: Ameren, CenterPoint, South Jersey Industries, Boston Beer and Ollie's
We have selected five stocks that are undeterred by trade war risks; providing risk-adjusted returns and steady earnings regardless of the state of the equity market
Shares of Boston Beer Co. Inc. are up 1.8% in midday trading Friday after Susquehanna Financial Group analyst Pablo Zuanic raised his price target on the stock to $305 from $221. "Yes, we are chasing the rally here, but in all fairness the very successful innovation around hard cider, hard seltzer, the new Sam'76 (a more approachable craft beer), and sustained 20% plus growth in hard tea, has caught even management by surprise, if we go by guidance and apparent stock outs," Zuanic wrote.
Investors in Molson Coors Brewing Co (NYSE:TAP) have to be disappointed so far this year. TAP stock is down more than 22% so far in 2018 and more than 27% over the past 12 months. While Molson now yields 2.6%, investors have to be asking themselves if it’s time to pass on this brew and look for a more refreshing stock.
AB InBev's (BUD) dismal show in the recent past is mainly due to its soft earnings trend. Also, volatility in certain key markets remains a hurdle.
Consllation Brands' (STZ) consistent focus on brand building and its initiatives to include new products are the key revenue drivers for the stock.
Typically, most investors don’t actively seek out so-called vice stocks. For instance, an investor can rail against tobacco companies on moral grounds. Another reason to at least be open to vice stocks is market performance.
Boston Beer (SAM) looks promising on the back of its growth plan focused on the revival of its Samuel Adams and Angry Orchard brands, cost-saving initiatives and long-term innovation.
The Zacks Analyst Blog Highlights: Herbalife, United Natural, Natural Grocers and Boston Beer
NEW YORK, May 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Oritani ...
Boston Beer's (SAM) three-point growth plan focused on the revival of its Samuel Adams and Angry Orchard brands, cost-saving initiatives and long-term innovation, is aiding stock performance.
Clorox (CLX) is gaining from a robust surprise trend as well progress on its 2020 Strategy and e-commerce initiatives. However, the company's soft margins are keeping us on the sidelines.
AB InBev (BUD) reports lower-than-expected earnings per share in first-quarter 2018 while sales beat estimates. Sales gain from strong global brands and revenue management initiatives.
The 15 most expensive beers in the world not only come with a hefty price tag but are also available in limited quantities. Beer is the most popular alcoholic beverage in the U.S and many other countries across the globe, with per capita beer consumption being highest in the Czech Republic. According to Allied Market […]
Zacks.com highlights: Rocky Brands, Boston Beer, Conagra Brands, DMC Global and United States Cellular
In this article we present a strategy which clearly shows less risky securities could also reward investors with impressive returns.
Boston Beer’s new CEO David Burwick said he was drawn to the position because of founder Jim Koch, making the shift from Peet’s Coffee to the biggest name in craft beer because of Koch’s vision and the trajectory of the company.